Skip to main content
SpringerLink
Log in

Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

Previous studies have focused on the association of a gene (EPHX1) encoding microsomal epoxide hydrolase with the carcinogenesis of hepatocellular carcinoma (HCC). In the present study, we performed a meta-analysis to systematically summarize the possible association between EPHX1 genetic polymorphisms and the risk for HCC. We conducted a search of case–control studies on the associations of EPHX1 genetic polymorphisms with susceptibility to HCC in PubMed, EMBASE, ISI Web of Science, Wanfang database in China, and the Chinese National Knowledge Infrastructure databases. Data from eligible studies were extracted for meta-analysis. HCC risk associated with EPHX1 genetic polymorphism was estimated by pooled odds ratios and 95 % confidence intervals. Thirteen studies were included in the present meta-analysis. Our results showed that, for the two polymorphisms (337 T > C and 416A > G) of EPHX1 gene, neither allele frequency nor genotype distributions were associated with risk for HCC in all genetic models (all P > 0.05). This meta-analysis suggests that EPHX1 genetic polymorphisms were not associated with the risk of HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–76.

    Article  CAS  PubMed  Google Scholar 

  2. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118–27.

    Article  CAS  PubMed  Google Scholar 

  3. Coleman WB. Mechanisms of human hepatocarcinogenesis. Curr Mol Med. 2003;3:573–88.

    Article  CAS  PubMed  Google Scholar 

  4. McGlynn KA, Rosvold EA, Lustbader ED, Hu Y, Clapper ML, et al. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci U S A. 1995;92:2384–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Shen F, Hu Y. Association between the gene polymorphism of epoxide hydrolase and the susceptibility to primary hepatocellular carcinoma. Chin J Med Genet. 1997;14:96–8.

    Google Scholar 

  6. Wong NA, Rae F, Bathgate A, Smith CA, Harrison DJ. Polymorphisms of the gene for microsomal epoxide hydrolase and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a Caucasian population. Toxicol Lett. 2000;115:17–22.

    Article  CAS  PubMed  Google Scholar 

  7. Tiemersma EW, Omer RE, Bunschoten A, van’t Veer P, Kok FJ, et al. Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 2001;10:785–91.

    CAS  PubMed  Google Scholar 

  8. Sonzogni L, Silvestri L, De Silvestri A, Gritti C, Foti L, et al. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV related liver disease. Hepatology. 2002;36:195–201.

    Article  CAS  PubMed  Google Scholar 

  9. McGlynn KA, Hunter K, LeVoyer T, Roush J, Wise P, et al. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Cancer Res. 2003;63:4594–601.

    CAS  PubMed  Google Scholar 

  10. Cao YY, Bian JC, Jiang F, Zhang ZM, Wang QM, et al. Association between the genetic polymorphism of epoxide hydrolase and the genetic susceptibility to primary liver cancer. Fudan Univ J Med Sci. 2004;31:363–7.

    CAS  Google Scholar 

  11. Kirk GD, Turner PC, Gong Y, Lesi OA, Mendy M, et al. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. Cancer Epidemiol Biomarkers Prev. 2005;14:373–9.

    Article  CAS  PubMed  Google Scholar 

  12. Long XD, Ma Y, Wei YP, Deng ZL. The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatol Res. 2006;36:48–55.

    Article  CAS  PubMed  Google Scholar 

  13. Kiran M, Chawla YK, Kaur J. Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viral-related hepatocellular carcinoma risk in India. DNA Cell Biol. 2008;27:687–94.

    Article  CAS  PubMed  Google Scholar 

  14. He SJ, Gu YY, Lin WZ, Zeng XY, Liao ZH. Polymorphism of microsomal epoxide hydrolase and susceptibility to primary hepatocellular carcinoma. Tumor. 2008;28:125–8.

    CAS  Google Scholar 

  15. Wei YP, Ma Y, Deng ZL. Aflatoxin high-risk patients with hepatocellular carcinoma microsomal oxide hydrolase gene detection. Zhong Liu Fang Zhi Za Zhi. 2003;10:1009–11.

    CAS  Google Scholar 

  16. Liu ZG. Detoxifying enzyme gene GSTT-1, EPHX polymorphisms associated with hepatocellular carcinoma. Guangxi: Guangxi Medical University; 2003. p. 1–80.

    Google Scholar 

  17. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet. 1994;3:421–8.

    Article  CAS  PubMed  Google Scholar 

  18. Goode EL, White KL, Vierkant RA, Phelan CM, Cunningham JM, et al. Xenobiotic-metabolizing gene polymorphisms and ovarian cancer risk. Mol Carcinog. 2011;50:397–402.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Pinarbasi H, Silig Y, Pinarbasi E. Microsomal epoxide hydrolase polymorphisms. Mol Med Report. 2010;3:723–7.

    CAS  Google Scholar 

  20. Zhong J-H, Xiang B-D, Ma L, You X-M, Li L-Q, et al. Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma. PLoS ONE. 2013;8:e57064. doi:10.1371/journal.pone.0057064.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Petitti DB. Approaches to heterogeneity in meta-analysis. Stat Med. 2001;20:3625–33.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Company Five of Cadet Brigade, Third Military Medical University, Chongqing, 400038, China

    Chen-Yang Duan

  2. Company Two of Cadet Brigade, Third Military Medical University, Chongqing, 400038, China

    Meng-Ying Liu

  3. Company Ono of Cadet Brigade, Third Military Medical University, Chongqing, 400038, China

    Shao-bo Li

  4. Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China

    Kuan-sheng Ma & Ping Bie

Authors
  1. Chen-Yang Duan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meng-Ying Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shao-bo Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kuan-sheng Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ping Bie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kuan-sheng Ma.

Additional information

Chen-Yang Duan and Meng-Ying Liu contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duan, CY., Liu, MY., Li, Sb. et al. Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis. Tumor Biol. 35, 659–666 (2014). https://doi.org/10.1007/s13277-013-1090-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1090-7

Keywords

Search

Navigation